Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.

Hoang T, Aagaard C, Dietrich J, Cassidy JP, Dolganov G, Schoolnik GK, Lundberg CV, Agger EM, Andersen P.

PLoS One. 2013 Dec 12;8(12):e80579. doi: 10.1371/journal.pone.0080579. eCollection 2013.

PMID:
24349004
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations.

Christensen D, Foged C, Rosenkrands I, Lundberg CV, Andersen P, Agger EM, Nielsen HM.

Int J Pharm. 2010 May 5;390(1):19-24. doi: 10.1016/j.ijpharm.2009.10.043. Epub 2009 Oct 29.

PMID:
19879346
[PubMed - indexed for MEDLINE]
3.

TB vaccine strategies--what is needed to solve a complex problem?

Dietrich J, Lundberg CV, Andersen P.

Tuberculosis (Edinb). 2006 May-Jul;86(3-4):163-8. Review.

PMID:
16678489
[PubMed - indexed for MEDLINE]
4.

Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application.

Høegh-Andersen P, Tankó LB, Andersen TL, Lundberg CV, Mo JA, Heegaard AM, Delaissé JM, Christgau S.

Arthritis Res Ther. 2004;6(2):R169-80. Epub 2004 Feb 19.

PMID:
15059281
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk